Cardinal Health CAH

Cardinal Health has upgraded its fiscal-year adjusted earnings guidance for 2026 to a range of $10.70 to $10.80 per share, an increase from the previous forecast of $10.15 to $10.35, following a strong third-quarter where it reported adjusted earnings of $3.17 per share and total revenues of $60.94 billion. The impressive results were driven by robust demand in the pharmaceutical and specialty solutions segment, contributing significantly to an 11.1% year-on-year revenue increase. Despite these positive developments, Cardinal Health's stock is down 4.3% over the past month, though analysts maintain an optimistic 'Strong Buy' outlook.